HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elena K Schneider-Futschik Selected Research

octapeptin antibiotics

11/2018Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elena K Schneider-Futschik Research Topics

Disease

18Cystic Fibrosis (Mucoviscidosis)
04/2024 - 01/2018
7Infections
02/2023 - 11/2018
3Pneumonia (Pneumonitis)
01/2023 - 07/2021
2Inflammation (Inflammations)
01/2023 - 06/2022
2Asthma (Bronchial Asthma)
11/2021 - 10/2021
2Bacterial Infections (Bacterial Infection)
05/2020 - 01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
04/2024
1Staphylococcal Infections
02/2023
1COVID-19
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Hyperthermia
07/2021
1Central Nervous System Infections (Central Nervous System Infection)
12/2020
1Dehydration (Water Stress)
11/2019
1Ebola Hemorrhagic Fever
11/2019
1Hallucinations (Hallucination)
01/2019
1Paresthesia (Dysesthesia)
01/2019
1Dizziness (Lightheadedness)
01/2019
1Seizures (Absence Seizure)
01/2019
1Confusion (Bewilderment)
01/2019
1Vertigo (Positional Vertigo)
01/2019
1Ataxia (Dyssynergia)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2019

Drug/Important Bio-Agent (IBA)

9Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
04/2024 - 01/2019
6ivacaftorIBA
06/2022 - 06/2020
6Polymyxins (Polymyxin)IBA
12/2020 - 01/2018
4Anti-Bacterial Agents (Antibiotics)IBA
02/2023 - 11/2018
4Polymyxin B (Aerosporin)FDA LinkGeneric
06/2020 - 01/2018
3ivacaftor drug combination tezacaftorIBA
01/2024 - 10/2020
3Drug CombinationsIBA
01/2024 - 10/2020
3elexacaftorIBA
01/2024 - 10/2020
2LipopolysaccharidesIBA
01/2023 - 06/2022
2ivacaftor drug combination lumacaftorIBA
01/2021 - 01/2019
2teixobactinIBA
05/2020 - 01/2020
2Colistin (Coly-Mycin)FDA Link
01/2019 - 11/2018
1PowdersIBA
05/2023
1ChloridesIBA
03/2023
1Claudin-4IBA
01/2023
1Epithelial Cell Adhesion MoleculeIBA
01/2023
1CytokinesIBA
06/2022
1lumacaftorIBA
01/2022
1AerosolsIBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
10/2021
1Drug CarriersIBA
07/2021
1Sertraline (Zoloft)FDA LinkGeneric
12/2020
1tezacaftorIBA
10/2020
1Ion Channels (Ion Channel)IBA
02/2020
1PhenothiazinesIBA
01/2020
1Oxygen (Dioxygen)IBA
11/2019
1VaccinesIBA
11/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1octapeptin antibioticsIBA
11/2018
1LipopeptidesIBA
11/2018
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2018
1TamoxifenFDA LinkGeneric
01/2018

Therapy/Procedure

7Therapeutics
01/2023 - 11/2018
1Pain Management
11/2019